The H1N1 epidemic has illuminated the need for new rapid molecular tests. Opportunities for point-of-care have arisen around the need for faster turnaround time and more sophisticated assays that differentiate strain types of emerging agents and that generate reliable results. This promises to improve healthcare delivery and make patient management more efficient with accurate diagnosis. This conference will provide a forum to discuss the terms “meaningful use” and “comparative effective” that will govern how the tests will be reimbursed. Newer applications for point-of-care testing will also be explored that branch out from traditional markets and have the potential to greatly impact treatment. New developments in affordable and innovative options that represent cost savings in healthcare delivery will be given priority status.
Topics include:
Infectious and respiratory disease detection and diagnosis
Standards for POC testing
Clinical needs assessment
Implementation of POC tests and technical challenges
Impact of POC testing on clinical decision-making
Key issues that impact market success of molecular diagnostic tests
Mobile phone based technology
Navigating successful reimbursement
Sensor components for POC
Progress towards affordable diagnostics
POC assays for genetic, cardiac, stroke, HIV, emerging pathogens
If you would like to submit a proposal to give a podium presentation or display a poster at this meeting, please click here to submit a title and brief 3-5 sentence summary of a proposed topic on your recent work in the area of point-of-care diagnostics.
The deadline for submission is February 12, 2010.
All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program.
For more information, please contact Christina Lingham at:
Cambridge Healthtech Institute
250 First Ave, Suite 300
Needham, MA 02494
Tel: 781-972-5464
Fax: 781-972-5425
email: clingham@healthtech.com
For information on sponsorships and exhibits, please contact:
Arnie Wolfson
Manager, Business Development
Tel: 781-972-5431
email: awolfson@healthtech.com